4-miRNA signature and MGMT promoter methylation improve risk stratification in glioblastoma.

K. Unger; D. F. Fleischmann; V. Ruf; J. Felsberg; D. Piehlmaier; D. Samaga; J. Hess; M. Mittelbronn; K. Lauber; W. Budach; M. Sabel; C. Roedel; G. Reifenberger; J. Herms; J. Tonn; H. Zitzelsberger; C. Belka; M. Niyazi

doi:10.1016/S0167-8140(21)00346-7

4-miRNA signature and MGMT promoter methylation improve risk stratification in glioblastoma.

K. Unger, D. F. Fleischmann, V. Ruf, J. Felsberg, D. Piehlmaier, D. Samaga, J. Hess, M. Mittelbronn, K. Lauber, W. Budach, M. Sabel, C. Roedel, G. Reifenberger, J. Herms, J. Tonn, H. Zitzelsberger, C. Belka, M. Niyazi

Luxembourg Center of Neuropathology

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	OC-0322
Pages (from-to)	S169-S170
Journal	Radiotherapy and Oncology
Volume	152
Issue number	Suppl.1
DOIs	https://doi.org/10.1016/S0167-8140(21)00346-7
Publication status	Published - Nov 2020
Event	ESTRO 2020: Translating research and partnership into optimal health - Online congress Duration: 28 Nov 2020 → 1 Dec 2020

Access to Document

10.1016/S0167-8140(21)00346-7

Cite this

Unger, K., Fleischmann, D. F., Ruf, V., Felsberg, J., Piehlmaier, D., Samaga, D., Hess, J., Mittelbronn, M., Lauber, K., Budach, W., Sabel, M., Roedel, C., Reifenberger, G., Herms, J., Tonn, J., Zitzelsberger, H., Belka, C., & Niyazi, M. (2020). 4-miRNA signature and MGMT promoter methylation improve risk stratification in glioblastoma. Radiotherapy and Oncology, 152(Suppl.1), S169-S170. Article OC-0322. https://doi.org/10.1016/S0167-8140(21)00346-7

@article{c22c5e0574a0440b908f3e6c9b2451ce,

title = "4-miRNA signature and MGMT promoter methylation improve risk stratification in glioblastoma.",

author = "K. Unger and Fleischmann, {D. F.} and V. Ruf and J. Felsberg and D. Piehlmaier and D. Samaga and J. Hess and M. Mittelbronn and K. Lauber and W. Budach and M. Sabel and C. Roedel and G. Reifenberger and J. Herms and J. Tonn and H. Zitzelsberger and C. Belka and M. Niyazi",

year = "2020",

month = nov,

doi = "10.1016/S0167-8140(21)00346-7",

language = "English",

volume = "152",

pages = "S169--S170",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "Suppl.1",

note = "ESTRO 2020 : Translating research and partnership into optimal health ; Conference date: 28-11-2020 Through 01-12-2020",

}

Unger, K, Fleischmann, DF, Ruf, V, Felsberg, J, Piehlmaier, D, Samaga, D, Hess, J, Mittelbronn, M, Lauber, K, Budach, W, Sabel, M, Roedel, C, Reifenberger, G, Herms, J, Tonn, J, Zitzelsberger, H, Belka, C & Niyazi, M 2020, '4-miRNA signature and MGMT promoter methylation improve risk stratification in glioblastoma.', Radiotherapy and Oncology, vol. 152, no. Suppl.1, OC-0322, pp. S169-S170. https://doi.org/10.1016/S0167-8140(21)00346-7

TY - JOUR

T1 - 4-miRNA signature and MGMT promoter methylation improve risk stratification in glioblastoma.

AU - Unger, K.

AU - Fleischmann, D. F.

AU - Ruf, V.

AU - Felsberg, J.

AU - Piehlmaier, D.

AU - Samaga, D.

AU - Hess, J.

AU - Mittelbronn, M.

AU - Lauber, K.

AU - Budach, W.

AU - Sabel, M.

AU - Roedel, C.

AU - Reifenberger, G.

AU - Herms, J.

AU - Tonn, J.

AU - Zitzelsberger, H.

AU - Belka, C.

AU - Niyazi, M.

PY - 2020/11

Y1 - 2020/11

U2 - 10.1016/S0167-8140(21)00346-7

DO - 10.1016/S0167-8140(21)00346-7

M3 - Meeting Abstract

SN - 0167-8140

VL - 152

SP - S169-S170

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - Suppl.1

M1 - OC-0322

T2 - ESTRO 2020

Y2 - 28 November 2020 through 1 December 2020

ER -